FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amneal Pharmaceuticals traMADol Hydrochloride Tablets Recall

traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured b…

Amneal Pharmaceuticals, LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Apr 8, 2026
Recall ID
D-0408-2026
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled traMADol Hydrochloride Tablets starting Mar 19, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0408-2026 on Apr 8, 2026. Reason: Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH). Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

Product description

traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.

Lot numbers, UPCs & expiration codes

Lot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.

Where it was sold

Nationwide within the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0408-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 19, 2026
FDA report date
Apr 8, 2026
Quantity
29,542 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0408-2026, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
98623
Address
400 Crossing Blvd Fl 3
Code information
Lot #: AM230987, Exp. Date 05/2026; AR232387, Exp. Date 12/2026.
Postal code
08807-2863
Report date
Apr 8, 2026
Product type
Drugs
Recall number
D-0408-2026
Classification
Class II
Recalling firm
Amneal Pharmaceuticals, LLC
Product quantity
29,542 bottles
Reason for recall
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
Voluntary / mandated
Voluntary: Firm initiated
Product description
traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.
Distribution pattern
Nationwide within the USA
Recall initiation date
Mar 19, 2026
Center classification date
Mar 30, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0408-2026, published Apr 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls